🔗 Permalink

Inventor profile of:

Christine Gaucher

City:

Sequedin

Country:

France

Published Applications:

Last publication date:

2019-09-05

Top Assignees for applications by Christine Gaucher

The entities that hold a legal rights for patent applications filed by inventor Gaucher Christine:

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 9 Les Ulis, France
LFB BIOTECHNOLOGIES 3 Les Ulis, France
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES 1 F-91940 LES ULIS, France

Recent patent applications by Gaucher Christine

Christine Gaucher from Sequedin, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-09-05

US20190270801A1

Chemistry; metallurgy

Oral Composition of Anti-TNF-Alpha Antibodies

#2 | 2016-03-03

US20160060350A1

Chemistry; metallurgy

Antibody method for treatment of a disease in which the target cells are cells which express CD20

#3 | 2015-10-29

US20150307624A1

Chemistry; metallurgy

Use of ADCC-optimized antibodies for treating low-responder patients

#4 | 2014-01-16

US20140017243A1

Chemistry; metallurgy

Use of ADCC-optimized antibodies for treating weak patients

#5 | 2011-12-22

US20110311556A1

Chemistry; metallurgy

Anti-rhesus D monoclonal antibody

#6 | 2011-11-10

US20110274684A1

Chemistry; metallurgy

CYTOTOXIC ANTIBODIES DIRECTED AGAINST ANTIBODIES INHIBITING FACTOR VIII

#7 | 2010-12-23

US20100323368A1

Physics

Cytokine production-inducing antibody

#8 | 2010-12-02

US20100303826A1

Chemistry; metallurgy

Use of ADCC-optimized antibodies for treating weak patients

#9 | 2009-05-21

US20090130094A1

Chemistry; metallurgy

Cytotoxic antibodies directed against antibodies inhibiting factor VIII

#10 | 2009-03-26

US20090081216A1

Chemistry; metallurgy

TREATMENT OF PATHOLOGIES WHICH ESCAPE THE IMMUNE RESPONSE, USING OPTIMIZED ANTIBODIES

#11 | 2009-02-26

US20090053233A1

Chemistry; metallurgy

Monoclonal antibody directed against CD20 antigen

#12 | 2006-08-17

US20060182741A1

Chemistry; metallurgy

Use of ADCC-optimized antibodies for treating low-responder patients

#13 | 2005-12-08

US20050271652A1

Chemistry; metallurgy

Treatment of pathologies which escape the immune response, using optimised antibodies

#14 | 2005-11-10

US20050249732A1

Physics

Method of measuring activation of effector cells

InventorID:

613651 ⎘